Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Longhurst

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Arerugi = [Allergy]|December 15, 2015
[WAO Guideline for the Management of Hereditary Angioedema]Timothy Craig, Emel Aygören Pürsün, Konrad Bork, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedemaDipti Pawaskar, Michael A Tortorici, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiencyTeresa Caballero, Henriette Farkas, Laurence Bouillet, et al.
Asia Pacific Allergy|June 30, 2023
Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinentAnkur Kumar Jindal, Archan Sil, Ridhima Aggarwal, et al.
Kidney International Reports|June 7, 2023
Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and ManPlinio Ferreira, Ricky Vaja, Maria Lopes-Pires, et al.
Immunologic Research|September 24, 2024
Clinical profile and management of pediatric hereditary angioedema in resource-constrained settings: our experience from a single centre in North IndiaAnkur Kumar Jindal, Prabal Barman, Suprit Basu, et al.
Orphanet Journal of Rare Diseases|July 29, 2021
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Arerugi = [Allergy]|December 15, 2015
[WAO Guideline for the Management of Hereditary Angioedema]Timothy Craig, Emel Aygören Pürsün, Konrad Bork, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2018
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedemaDipti Pawaskar, Michael A Tortorici, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiencyTeresa Caballero, Henriette Farkas, Laurence Bouillet, et al.
Asia Pacific Allergy|June 30, 2023
Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinentAnkur Kumar Jindal, Archan Sil, Ridhima Aggarwal, et al.
Kidney International Reports|June 7, 2023
Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and ManPlinio Ferreira, Ricky Vaja, Maria Lopes-Pires, et al.
Immunologic Research|September 24, 2024
Clinical profile and management of pediatric hereditary angioedema in resource-constrained settings: our experience from a single centre in North IndiaAnkur Kumar Jindal, Prabal Barman, Suprit Basu, et al.
Orphanet Journal of Rare Diseases|July 29, 2021
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Pageof 8